Diabetes Care in Mexico
In 1995 there were an estimated 3.8 million patients with diabetes in México; this number increased to 5 million in 2000, and has been projected to 11.7 million in 2025. Diabetes is now the leading cause of mortality for women and the second leading cause for men in México.
The Méxican Ministry of Health has generated criteria for diagnosing impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) that enable initiation of early treatment to either prevent or delay the onset of long-term diabetic complications, and the World Health Organization (WHO) and International Diabetes Federation (IDF) have also published guidelines for screening, diagnosis, and treatment of diabetes.

Diabetes Care in Argentina
In Argentina, the incidence of type 1 diabetes is 8 per 100,000 persons, and type 2 diabetes afflicts 7% of the entire adult population. The medical expenditures incurred by patients with diabetes are 2- 3 times greater than they are for people without diabetes. The World Health Organization (WHO) and International Diabetes Federation (IDF) have published guidelines for screening, diagnosis, and treatment of diabetes. Several studies conducted in Argentina were designed to assess the benefits provided by specific types of intervention for patients with diabetes.

Diabetes Care in Brasil
In 2000, there were 4.6 million patients with diabetes in Brasil, making it the country with the eighth highest diabetes prevalence rate in the world. By 2030, the total number of cases is projected to reach 11.3 million, which will make Brasil the country with the sixth largest population of diabetes patients. The World Health Organization (WHO) and International Diabetes Federation (IDF) have published guidelines for screening, diagnosis, and treatment of diabetes. An analysis of Brasilian death certificates revealed that the underlying causes of death were listed as diabetes in 38.5%, cardiovascular diseases in 37.2%, respiratory diseases in 8.5%, and neoplasms in 4.8%. The prevalence of diabetic microvascular complications among Brasilian patients has been reported as 29.1% for retinopathy, 11.3% for nephropathy, and 50.9% for neuropathy.